BioDelivery Sciences to Participate in the Piper Sandler 32nd Annual Healthcare Conference

Rhea-AI Summary

BioDelivery Sciences International (NASDAQ: BDSI) announced the participation of CEO Jeff Bailey and CFO Terry Coelho at the Piper Sandler 32nd Annual Healthcare Conference. They will engage in a pre-recorded fireside chat available from November 23 to December 3. BDSI will also host 1x1 investor meetings on December 2 and 3, which can be requested through Piper Sandler.

BDSI focuses on treating serious chronic conditions with innovative therapies, including managing chronic pain and opioid-induced constipation.

RALEIGH, N.C., Nov. 20, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that Jeff Bailey, Chief Executive Officer, and Terry Coelho, Chief Financial Officer, will participate in a fireside chat and 1x1 investor meetings at the Piper Sandler 32^nd Annual Healthcare Conference.

The pre-recorded fireside chat will be available for viewing beginning November 23^rd through December 3^rd by accessing the recording library on the Piper Sandler conference site. BDSI will be hosting 1x1 investor meetings on Wednesday, December 2^nd and Thursday, December 3^rd. Meetings may be requested exclusively via Piper Sandler.

ABOUT BIODELIVERY SCIENCES INTERNATIONAL, INC.

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSI's marketed products address serious and debilitating conditions, including chronic pain and opioid-induced constipation.

© 2020 BioDelivery Sciences International, Inc.  All rights reserved.

Contact:

Terry Coelho
Chief Financial Officer
BDSI_IR@bdsi.com 

Bob Yedid
LifeSci Advisors
(646) 597-6989
bob@lifesciadvisors.com 

FAQ

When will the BDSI fireside chat be available for viewing?

The BDSI fireside chat will be available from November 23 to December 3.

What is the schedule for BDSI's 1x1 investor meetings?

BDSI will host 1x1 investor meetings on December 2 and 3.

How can I request a meeting with BDSI at the Piper Sandler conference?

Meetings with BDSI can be requested exclusively via Piper Sandler.

Who is participating in the fireside chat for BDSI?

CEO Jeff Bailey and CFO Terry Coelho will participate in the fireside chat.

What are the primary products and focus of BioDelivery Sciences International?

BDSI focuses on chronic pain and opioid-induced constipation through innovative therapies.